Thrombopoietin receptor agonists can be used temporarily with patients suffering from refractory chronic lymphocytic leukemia-associated immunologic thrombocytopenia.

M Sinisalo; M Sankelo; M Itälä-Remes

Thrombopoietin receptor agonists can be used temporarily with patients suffering from refractory chronic lymphocytic leukemia-associated immunologic thrombocytopenia.

M Sinisalo, M Sankelo, M Itälä-Remes

Research output: Contribution to journal › Article › Scientific › peer-review

14 Citations (Scopus)

Original language	English
Pages (from-to)	724-725
Journal	Leukemia & Lymphoma
Volume	52
Issue number	4
Publication status	Published - 2011
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://pubmed.ncbi.nlm.nih.gov/21323511

Cite this

@article{a0c71d689195445abe78dda79e68049f,

title = "Thrombopoietin receptor agonists can be used temporarily with patients suffering from refractory chronic lymphocytic leukemia-associated immunologic thrombocytopenia.",

author = "M Sinisalo and M Sankelo and M It{\"a}l{\"a}-Remes",

year = "2011",

language = "English",

volume = "52",

pages = "724--725",

number = "4",

}

TY - JOUR

T1 - Thrombopoietin receptor agonists can be used temporarily with patients suffering from refractory chronic lymphocytic leukemia-associated immunologic thrombocytopenia.

AU - Sinisalo, M

AU - Sankelo, M

AU - Itälä-Remes, M

PY - 2011

Y1 - 2011

M3 - Article

SN - 1042-8194

VL - 52

SP - 724

EP - 725

JO - Leukemia & Lymphoma

JF - Leukemia & Lymphoma

IS - 4

ER -